We further identified that enhanced expression of 7 genes namely CAV2, CIDEC, HILPDA, HSD17B11, NCEH1, RAB5A, and SQLE are associated with significantly shorter overall survival whereas elevated expression of BSCL2 and FITM1 correlates with longer overall survival of pancreatic cancer patients (Fig. 3a). The gene discussed is HSD17B11; the disease is pancreatic neoplasm.